Email this page: News Release

Affymax and Takeda Announce FDA Approval of OMONTYS® (Peginesatide) Injection for the Treatment of Anemia Due to Chronic Kidney Disease (CKD) in Adult Patients on Dialysis

To (email address):   Separate multiple addresses with commas. Maximum 200 characters.
Your name:
Your email address:   Copy yourself These email addresses will be used to email the page on your behalf and will not be used by Affymax, Inc. for any marketing purposes.
Add a comment:
Send:    Full page    Link to page
Type in number:
This helps Affymax, Inc. prevent automated submissions.